Skip to main content
AAN.com

Abstract

Objective:

Idiopathic REM sleep behavior disorder is a parasomnia characterized by dream enactment and is commonly a prediagnostic sign of parkinsonism and dementia. Since risk factors have not been defined, we initiated a multicenter case-control study to assess environmental and lifestyle risk factors for REM sleep behavior disorder.

Methods:

Cases were patients with idiopathic REM sleep behavior disorder who were free of dementia and parkinsonism, recruited from 13 International REM Sleep Behavior Disorder Study Group centers. Controls were matched according to age and sex. Potential environmental and lifestyle risk factors were assessed via standardized questionnaire. Unconditional logistic regression adjusting for age, sex, and center was conducted to investigate the environmental factors.

Results:

A total of 694 participants (347 patients, 347 controls) were recruited. Among cases, mean age was 67.7 ± 9.6 years and 81.0% were male. Cases were more likely to smoke (ever smokers = 64.0% vs 55.5%, adjusted odds ratio [OR] = 1.43, p = 0.028). Caffeine and alcohol use were not different between cases and controls. Cases were more likely to report previous head injury (19.3% vs 12.7%, OR = 1.59, p = 0.037). Cases had fewer years of formal schooling (11.1 ± 4.4 years vs 12.7 ± 4.3, p < 0.001), and were more likely to report having worked as farmers (19.7% vs 12.5% OR = 1.67, p = 0.022) with borderline increase in welding (17.8% vs 12.1%, OR = 1.53, p = 0.063). Previous occupational pesticide exposure was more prevalent in cases than controls (11.8% vs 6.1%, OR = 2.16, p = 0.008).

Conclusions:

Smoking, head injury, pesticide exposure, and farming are potential risk factors for idiopathic REM sleep behavior disorder.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (appendix_e-1.doc)
File (postuma.pdf)
File (postuma_79__428.pdf)
File (table_e-1.docx)
File (znl02912000402.pdf)

REFERENCES

1.
Schenck CH, Bundlie SR, Patterson AL, Mahowald MW. Rapid eye movement sleep behavior disorder: a treatable parasomnia affecting older adults. JAMA 1987; 257: 1786– 1789.
2.
Gagnon JF, Postuma RB, Mazza S, Doyon J, Montplaisir J. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 2006; 5: 424– 432.
3.
Boeve BF, Silber MH, Saper CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007; 130: 2770– 2788.
4.
Iranzo A, Molinuevo JL, Santamaria J, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006; 5: 572– 577.
5.
Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996; 46: 388– 393.
6.
Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009; 72: 1296– 1300.
7.
Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C. Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 2011; 77: 1048– 1054.
8.
Gagnon JF, Vendette M, Postuma RB, et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Ann Neurol 2009; 66: 39– 47.
9.
Postuma RB, Gagnon JF, Vendette M, Charland K, Montplaisir J. Manifestations of Parkinson disease differ in association with REM sleep behavior disorder. Mov Disord 2008; 23: 1665– 1672.
10.
Postuma RB, Gagnon JF, Vendette M, Massicotte-Marquez J, Charland K, Montplaisir J. REM sleep behavior disorder in Parkinson's disease is associated with specific motor features. J Neurol Neurosurg Psychiatry 2008; 79: 1117– 1121.
11.
Onofrj M, Bonanni L, Albani G, Mauro A, Bulla D, Thomas A. Visual hallucinations in Parkinson's disease: clues to separate origins. J Neurol Sci 2006; 248: 143– 150.
12.
Boeve BF, Silber MH, Parisi JE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003; 61: 40– 45.
13.
Dugger BN, Boeve BF, Murray ME, et al. Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies. Mov Disord Epub 2011.
14.
American Academy of Sleep Disorders. International Classification of Sleep Disorders–2. Westchester, IL: American Academy of Sleep Disorders; 2005.
15.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189– 198.
16.
Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181– 184.
17.
Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002; 52: 276– 284.
18.
Caamano-Isorna F, Corral M, Montes-Martinez A, Takkouche B. Education and dementia: a meta-analytic study. Neuroepidemiology 2006; 26: 226– 232.
19.
Lai BC, Marion SA, Teschke K, Tsui JK. Occupational and environmental risk factors for Parkinson's disease. Parkinsonism Relat Disord 2002; 8: 297– 309.
20.
Anstey KJ, von SC, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007; 166: 367– 378.
21.
Van Den Heuvel C, Thornton E, Vink R. Traumatic brain injury and Alzheimer's disease: a review. Prog Brain Res 2007; 161: 303– 316.
22.
Bender R, Lange S. Adjusting for multiple testing: when and how? J Clin Epidemiol 2001; 54: 343– 349.

Information & Authors

Information

Published In

Neurology®
Volume 79Number 5July 31, 2012
Pages: 428-434
PubMed: 22744670

Publication History

Received: August 31, 2011
Accepted: December 29, 2011
Published online: June 27, 2012
Published in print: July 31, 2012

Permissions

Request permissions for this article.

Disclosure

The authors report no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.

Authors

Affiliations & Disclosures

R.B. Postuma, MD, MSc
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
Teva Neurosciences, Panel Member, 2008
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Allergan, 2011; Teva Neurosciences, 2011
Editorial Boards:
1.
Editorial Board, Movement Disorders Journal; Editorial Board, Journal of Caffeine Research
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Operating Grant - Canadian Institute of Health Research/Parkinson Society of Canada, grant number 201317, Principal Investigator (10/2009 – 10/2011); Operating Grant – Canadian Institute of Health Research, grant number 192205, co-Principal Investigator (07/2009 – 06/2010); 3. Operating Grant - Canadian Institute of Health Research, grant number 166206 Co-investigator (07/2007 to 06/2012); An Emerging Team in Mobility in Aging Operating Grant - Canadian Institute of Health Research, Co-investigator (01/2009 – 12/1013); Fonds de Recherche de la Sante Quebec, grant number 9965, Principal Investigator (2006-2009)
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Operating Grant – Weston Foundation, Prinicipal Investigator (01/2009 – 01/2011); Operating grant - Drummond Foundation, Principal Investigator (01/2008 - 04/2009)
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
J.Y. Montplaisir, MD, PhD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
Servier, advisor, 2009; Merck, advisor, 2009
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
GlaxoSmithKline, World Congress of Sleep Apnea, speaker, Korea 2009; Sanofi-Aventis, The Art of Good SleepMeeting, speaker, France 2009; Valeant Pharmaceutical, Speaker 2010 and 2011; Otsuka Pharmaceutical, Speaker, Japan 2011
Editorial Boards:
1.
Associate editor: Sleep Medicine; Associate editor: Sleep Medicine Reviews
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Sanofi-Aventis, 2009 - Unraleted to the study Merck 2010 - Unraleted to the study GlaxoSmithKline 2011 - Unralted to the study
Research Support, Government Entities:
1.
PI: CIHR - MOP-62955 - 2008-2013; PI: CIHR - NFP-88373 – 2008 – 2008; PI: CIHR- MGC-77493 – 2005-2010; PI: CIHR - MOP 74542 – 2005-2010; Co-PI: CIHR - MOP- 173519 – 2007-2012; Co-PI: CIHR - MOP-64221 – 2007-2012; Co-PI: CIHR - MOP 11701 – 2006-2011
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
A. Pelletier, PhD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Y. Dauvilliers, MD, PhD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
Pr. Dauvilliers has consulted for UCB Pharma, Sanofi- Aventis, Cephalon, Bioprojet, and Novartis
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Pr. Dauvilliers has consulted for UCB Pharma, Sanofi- Aventis, Cephalon, Bioprojet, and Novartis
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Pr. Dauvilliers has consulted for UCB Pharma, Sanofi- Aventis, Cephalon, Bioprojet, and Novartis Speakers’ Bureaus: Pr. Dauvilliers has consulted for UCB Pharma, Sanofi- Aventis, Cephalon, Bioprojet, and Novartis
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
W. Oertel, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
Boehringer Ingelheim; Merck-Serono; Merck-Sharp and Dohme; Novartis; UCB
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Boehringer Ingelheim; Novartis; Orion-Pharma; Phytopharm; UCB; Teva
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Desitin; Novartis; Phytopharm; Bioprojet; UCB
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Michael J Fox Foundation; International Parkinson Foundation; National Parkinson Foundation
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
pramipexol in the indication therapy of restless legs syndrome - Boehringer Ingelheim
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
A. Iranzo, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
L. Ferini-Strambi, MD, PhD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
Served on the scientific advisory boards for UCB-Pharma, Boehringer-Ingheleim, GSK, Sanofi-Aventis, Transcept Pharma
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Sleep Medicine, Field Editor, (2008-2010)
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
I. Arnulf, MD, PhD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
UCB Pharmaceutical, scientific advisory board, 2009- 2011; Sanofi Adventice, one meeting for giving advice, 2010
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
UCB pharmaceutical, 2009, Received travel expenses and speaker honoraria; Sanofi Adventice, received speaker honoraria
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
France Health Ministry (PHRC AOM07-138), PI, 2008- 2011 (narcolepsy bank)
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Kleine-Levin Syndrome Foundation, 2011
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
B. Hogl, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
UCB; Boehringer Ingelheim; GSK; Pfizer
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
UCB; Otsuka; Boehringer Ingelheim; GSK; Pfizer; Cephalon; Sanofi
Editorial Boards:
1.
J Clin Sleep Med; Sleep Med; Somnologie
Patents:
1.
NONE
Publishing Royalties:
1.
Sleep Medicine, Cambridge University Press, 2008
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
UCB; Boehringer Ingelheim; GSK; Pfizer
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Austrian National Bank Anniversary Funds (grant number 12594)
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
R. Manni, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Epilepsy research and treatment; Associate editor; 2009- 2010
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
T. Miyamoto, MD, PhD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
G. Mayer, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
UCB Pharma; Genzyme; Paul Ehrlich Institute
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
UCB Pharma, Brussels, Belgium; Genzyme, Neu Isenburg, Germany; Lilly Germany; Takeda, Japan
Editorial Boards:
1.
Editor of German Journal
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Cephalon sponsored study on modafinils effect on patients with idiopathic hypersomnia
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
Department of Neurology, Philipps-University, Marburg Germany
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
K. Stiasny-Kolster, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
I received honoraria for serving on the scientific advisory boards for UCB.
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
I received honoraria for speaking engagements sponsored by UCB
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
I received honoraria for consulting activities from UCB Speakers’ Bureaus: I received honoraria for speaking engagements sponsored by UCB
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
M. Puligheddu, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Y. Ju, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
American Sleep Medicine Foundation
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
P. Jennum, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
K. Sonka, MD, PhD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
UCB Pharma
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Prague Medical Report, 1992 - 2011; Neurologie pro praxi, 2003 - 2011; Neurologia (Bratislava), 2005 - 2011 Speakers’ Bureaus:; GlaxoSmithKline; UCB Pharma
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
Clinical trial participation: UCB Pharma; Clinical trial participation: Bioprojet
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Ministry of Education of the Czech Republic - grant VZ 0021620816
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
J. Santamaria, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
I perform polysomnographic studies in an Academic Public Health System Hospital in Barcelona)30% of my working time Neurology Service,Hospital Clínic of Barcelona, Barcelona, Spain
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
M.L. Fantini, MD, MSc
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
M. Zucconi, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
S. Leu-Semenescu, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
B. Frauscher, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Cephalon, UCB: support for congress participation.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Pfitzer Inc., Mundipharma
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
UCB: paid speaking engagement
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
M. Terzaghi, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
M. Miyamoto, MD, PhD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
M.M. Unger, MD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Michael J. Fox Foundation for Parkinson Research
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
V. Cochen De Cock, MD, PhD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Travel grants from Bohringer Ingelheim, Glaxo Smith Klein . Speaker honoraria from Lundbeck and UCB
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
C. Wolfson, PhD
From the Departments of Neurology (R.B.P., A.P.) and Epidemiology and Biostatistics and Occupational Health (J.Y.M.), McGill University, Montreal General Hospital, Montreal; Centre d'Études Avancées en Médecine du Sommeil (R.B.P., J.Y.M.), Hôpital du Sacré-Cœur de Montréal, Montréal; Research Institute of the McGill University Health Center (C.W.), Montreal; Department of Psychiatry (A.P., C.W.), Université de Montréal, Montreal, Canada; Department of Neurology (Y.D., V.C.D.C.), Hôpital Gui de Chauliac, Montpellier, INSERM U1061, Montpellier, France; Philipps-Universität (W.O., K.S.-K., M.M.U.), Marburg, Germany; Neurology Service (A.I., J.S.), Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Sleep Disorders Center (L.F.-S., M.L.F., M.Z.), Università Vita-Salute San Raffaele, Milan, Italy; Unité des Pathologies du Sommeil (I.A., S.L.-S.), Hôpital Pitié-Salpêtrière, APHP, and Inserm U975-CRICM-Pierre and Marie Curie University, Paris, France; Department of Neurology (B.H., B.F.), Innsbruck Medical University, Innsbruck, Austria; Unit of Sleep Medicine (R.M., M.T.), National Institute of Neurology IRCCS “C. Mondino Foundation,” Pavia, Italy; Department of Neurology (T.M.), Dokkyo Medical University Koshigaya Hospital, Saitama, Japan; Hephata Klinik (G.M.), Schwalmstadt-Treysa, Germany; Sleep Center (M.P.), Department of Cardiovascular and Neurological Sciences, University of Cagliari, Italy; Washington University Multidisciplinary Sleep Center (Y.J.), St. Louis, MO; Danish Center for Sleep Medicine (P.J.), University of Copenhagen, Denmark; Department of Neurology (K.S.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; and Department of Neurology (M.M.), Dokkyo Medical University School of Medicine, Tochigi, Japan.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers’ Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Study funding: Funded by grants from the Fonds de la Recherche en Sante Quebec.
Correspondence & reprint requests to Dr. Postuma: [email protected]

Author Contributions

R.B. Postuma was responsible for drafting the manuscript, study concept, acquisition of data, and analysis and interpretation of data. C. Wolfson was responsible for study concept, interpretation of data, and revision of manuscript. A. Pelletier was responsible for interpretation of data and revision of manuscript. J.Y. Montplaisir and Y. Dauvilliers were responsible for acquisition of data, analysis of data, and revision of the manuscript. W. Oertel, A. Iranzo, L. Ferini-Strambi, I. Arnulf, B. Hogl, R. Manni, T. Miyamoto, G. Mayer, K. Stiasny-Kolster, M. Puligheddu, Y. Ju, P. Jennum, K. Sonka, J. Santamaria, M.L. Fantini, M. Zucconi, S. Leu-Semenescu, B. Frauscher, M. Miyamoto, M. Terzaghi, M. Miyamoto, M. Unger, and V. Cochen De Cock were responsible for acquisition of data and revision of the manuscript.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Causal associations between modifiable risk factors and isolated REM sleep behavior disorder: a mendelian randomization study, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1321216
    Crossref
  2. The Body, the Brain, the Environment, and Parkinson’s Disease, Journal of Parkinson's Disease, 14, 3, (363-381), (2024).https://doi.org/10.3233/JPD-240019
    Crossref
  3. Causal Associations between Tea Consumption and Rapid Eye Movement Sleep Behavior Disorder: A Mendelian Randomization Study, European Neurology, (1-11), (2024).https://doi.org/10.1159/000541288
    Crossref
  4. REM sleep and neurodegeneration, Journal of Sleep Research, (2024).https://doi.org/10.1111/jsr.14263
    Crossref
  5. Secondary RBD: Not just neurodegeneration, Sleep Medicine Reviews, 76, (101938), (2024).https://doi.org/10.1016/j.smrv.2024.101938
    Crossref
  6. High bioavailable testosterone levels increase the incidence of isolated REM sleep behavior disorder: Results from multivariable and network Mendelian randomization analysis, Sleep Medicine, 121, (102-110), (2024).https://doi.org/10.1016/j.sleep.2024.06.024
    Crossref
  7. Educational Resources to Support Patients with Parasomnias, Sleep Medicine Clinics, 19, 1, (199-210), (2024).https://doi.org/10.1016/j.jsmc.2023.12.002
    Crossref
  8. ՊԱՐԿԻՆՍՈՆԻ ՀԻՎԱՆԴՈՒԹՅԱՄԲ ԲՈՒԺԱՌՈՒՆԵՐԻ ՇԱՐԺՈՂԱԿԱՆ ԽԱՆԳԱՐՈՒՄՆԵՐԻ ԽՈՐԱՑՈՒՄԸ` ՊԱՅՄԱՆԱՎՈՐՎԱԾ ՆԻԿՈՏԻՆԻ (ԾԽԱԽՈՏԻ) ԸՆԴՈՒՆՄԱՆ ԴԱԴԱՐԵՑՄԱՄԲ, MEDICINE, SCIENCE AND EDUCATION, 36, (45-52), (2023).https://doi.org/10.56936/18291775-2023.36-45
    Crossref
  9. Transdiagnostic cognitive behavioral therapy for nightmares and parasomnias, Journal of Clinical Sleep Medicine, 19, 3, (499-509), (2023).https://doi.org/10.5664/jcsm.10374
    Crossref
  10. Occupational Exposure to Pesticides as a Risk Factor for Sleep Disorders, International Journal of Environmental Research and Public Health, 20, 4, (3149), (2023).https://doi.org/10.3390/ijerph20043149
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share